UMICORE (NVJP.DE) Fundamental Analysis & Valuation

FRA:NVJP • BE0974320526

Current stock price

17.25 EUR
+0.25 (+1.47%)
Last:

This NVJP.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. NVJP.DE Profitability Analysis

1.1 Basic Checks

  • NVJP had positive earnings in the past year.
  • NVJP had a positive operating cash flow in the past year.
  • Of the past 5 years NVJP 4 years were profitable.
  • In the past 5 years NVJP always reported a positive cash flow from operatings.
NVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFNVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • NVJP has a better Return On Assets (4.07%) than 66.67% of its industry peers.
  • The Return On Equity of NVJP (17.17%) is better than 88.89% of its industry peers.
  • NVJP has a Return On Invested Capital of 9.87%. This is amongst the best in the industry. NVJP outperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA 4.07%
ROE 17.17%
ROIC 9.87%
ROA(3y)-2.6%
ROA(5y)0.96%
ROE(3y)-16.22%
ROE(5y)-2.52%
ROIC(3y)N/A
ROIC(5y)N/A
NVJP.DE Yearly ROA, ROE, ROICNVJP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • NVJP's Profit Margin of 1.98% is in line compared to the rest of the industry. NVJP outperforms 54.17% of its industry peers.
  • In the last couple of years the Profit Margin of NVJP has grown nicely.
  • NVJP's Operating Margin of 5.26% is in line compared to the rest of the industry. NVJP outperforms 50.00% of its industry peers.
  • In the last couple of years the Operating Margin of NVJP has grown nicely.
  • NVJP has a Gross Margin of 8.74%. This is amonst the worse of the industry: NVJP underperforms 81.94% of its industry peers.
  • NVJP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.26%
PM (TTM) 1.98%
GM 8.74%
OM growth 3Y16.82%
OM growth 5Y20.97%
PM growth 3Y-3.96%
PM growth 5Y25.7%
GM growth 3Y11.12%
GM growth 5Y9.99%
NVJP.DE Yearly Profit, Operating, Gross MarginsNVJP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

3

2. NVJP.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NVJP is still creating some value.
  • NVJP has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NVJP has about the same amount of shares outstanding.
  • Compared to 1 year ago, NVJP has an improved debt to assets ratio.
NVJP.DE Yearly Shares OutstandingNVJP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
NVJP.DE Yearly Total Debt VS Total AssetsNVJP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • NVJP has an Altman-Z score of 3.15. This indicates that NVJP is financially healthy and has little risk of bankruptcy at the moment.
  • NVJP has a Altman-Z score of 3.15. This is in the better half of the industry: NVJP outperforms 72.22% of its industry peers.
  • The Debt to FCF ratio of NVJP is 7.36, which is on the high side as it means it would take NVJP, 7.36 years of fcf income to pay off all of its debts.
  • NVJP has a Debt to FCF ratio (7.36) which is comparable to the rest of the industry.
  • NVJP has a Debt/Equity ratio of 1.00. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of NVJP (1.00) is worse than 76.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 7.36
Altman-Z 3.15
ROIC/WACC1.75
WACC5.64%
NVJP.DE Yearly LT Debt VS Equity VS FCFNVJP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • NVJP has a Current Ratio of 1.35. This is a normal value and indicates that NVJP is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.35, NVJP is not doing good in the industry: 70.83% of the companies in the same industry are doing better.
  • NVJP has a Quick Ratio of 1.35. This is a bad value and indicates that NVJP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NVJP's Quick ratio of 0.75 is on the low side compared to the rest of the industry. NVJP is outperformed by 80.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.75
NVJP.DE Yearly Current Assets VS Current LiabilitesNVJP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

5

3. NVJP.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 13.21% over the past year.
  • Measured over the past years, NVJP shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.18% on average per year.
  • NVJP shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.43%.
  • Measured over the past years, NVJP shows a decrease in Revenue. The Revenue has been decreasing by -1.32% on average per year.
EPS 1Y (TTM)13.21%
EPS 3Y-21.39%
EPS 5Y-2.18%
EPS Q2Q%12.28%
Revenue 1Y (TTM)30.43%
Revenue growth 3Y-8.67%
Revenue growth 5Y-1.32%
Sales Q2Q%6.94%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.96% on average over the next years. This is quite good.
  • NVJP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.75% yearly.
EPS Next Y17.13%
EPS Next 2Y14.76%
EPS Next 3Y13.39%
EPS Next 5Y12.96%
Revenue Next Year3.25%
Revenue Next 2Y3.51%
Revenue Next 3Y3.41%
Revenue Next 5Y2.75%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVJP.DE Yearly Revenue VS EstimatesNVJP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
NVJP.DE Yearly EPS VS EstimatesNVJP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

7

4. NVJP.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • NVJP is valuated correctly with a Price/Earnings ratio of 14.38.
  • NVJP's Price/Earnings ratio is a bit cheaper when compared to the industry. NVJP is cheaper than 79.17% of the companies in the same industry.
  • NVJP is valuated rather cheaply when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 12.27, which indicates a correct valuation of NVJP.
  • 84.72% of the companies in the same industry are more expensive than NVJP, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.36, NVJP is valued a bit cheaper.
Industry RankSector Rank
PE 14.38
Fwd PE 12.27
NVJP.DE Price Earnings VS Forward Price EarningsNVJP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • NVJP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NVJP is cheaper than 91.67% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, NVJP is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.01
EV/EBITDA 4.3
NVJP.DE Per share dataNVJP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NVJP has a very decent profitability rating, which may justify a higher PE ratio.
  • NVJP's earnings are expected to grow with 13.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y14.76%
EPS Next 3Y13.39%

5

5. NVJP.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.04%, NVJP has a reasonable but not impressive dividend return.
  • NVJP's Dividend Yield is comparable with the industry average which is at 3.18.
  • Compared to an average S&P500 Dividend Yield of 1.80, NVJP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

  • The dividend of NVJP has a limited annual growth rate of 0.03%.
Dividend Growth(5Y)0.03%
Div Incr Years1
Div Non Decr Years1
NVJP.DE Yearly Dividends per shareNVJP.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 15.64% of the earnings are spent on dividend by NVJP. This is a low number and sustainable payout ratio.
  • The dividend of NVJP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP15.64%
EPS Next 2Y14.76%
EPS Next 3Y13.39%
NVJP.DE Yearly Income VS Free CF VS DividendNVJP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B
NVJP.DE Dividend Payout.NVJP.DE Dividend Payout, showing the Payout Ratio.NVJP.DE Dividend Payout.PayoutRetained Earnings

NVJP.DE Fundamentals: All Metrics, Ratios and Statistics

UMICORE

FRA:NVJP (4/30/2026, 7:00:00 PM)

17.25

+0.25 (+1.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Industry Strength53.38
Industry Growth36.67
Earnings (Last)04-30
Earnings (Next)07-31
Inst Owners50.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.25B
Revenue(TTM)19.37B
Net Income(TTM)384.55M
Analysts71.43
Price Target18.84 (9.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Yearly Dividend0.25
Dividend Growth(5Y)0.03%
DP15.64%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.32%
PT rev (3m)12.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.88%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.35%
Revenue NY rev (3m)-3.63%
Valuation
Industry RankSector Rank
PE 14.38
Fwd PE 12.27
P/S 0.22
P/FCF 11.01
P/OCF 5.98
P/B 1.9
P/tB 2.3
EV/EBITDA 4.3
EPS(TTM)1.2
EY6.96%
EPS(NY)1.41
Fwd EY8.15%
FCF(TTM)1.57
FCFY9.08%
OCF(TTM)2.88
OCFY16.72%
SpS78.63
BVpS9.09
TBVpS7.5
PEG (NY)0.84
PEG (5Y)N/A
Graham Number15.6641 (-9.19%)
Profitability
Industry RankSector Rank
ROA 4.07%
ROE 17.17%
ROCE 19.55%
ROIC 9.87%
ROICexc 14.08%
ROICexgc 15.77%
OM 5.26%
PM (TTM) 1.98%
GM 8.74%
FCFM 1.99%
ROA(3y)-2.6%
ROA(5y)0.96%
ROE(3y)-16.22%
ROE(5y)-2.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.65%
ROICexgc growth 5Y22.55%
ROICexc growth 3Y9.92%
ROICexc growth 5Y22.04%
OM growth 3Y16.82%
OM growth 5Y20.97%
PM growth 3Y-3.96%
PM growth 5Y25.7%
GM growth 3Y11.12%
GM growth 5Y9.99%
F-Score8
Asset Turnover2.05
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 7.36
Debt/EBITDA 1.75
Cap/Depr 121.34%
Cap/Sales 1.68%
Interest Coverage 8.53
Cash Conversion 55.27%
Profit Quality 100.35%
Current Ratio 1.35
Quick Ratio 0.75
Altman-Z 3.15
F-Score8
WACC5.64%
ROIC/WACC1.75
Cap/Depr(3y)207.29%
Cap/Depr(5y)188.54%
Cap/Sales(3y)3.48%
Cap/Sales(5y)2.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.21%
EPS 3Y-21.39%
EPS 5Y-2.18%
EPS Q2Q%12.28%
EPS Next Y17.13%
EPS Next 2Y14.76%
EPS Next 3Y13.39%
EPS Next 5Y12.96%
Revenue 1Y (TTM)30.43%
Revenue growth 3Y-8.67%
Revenue growth 5Y-1.32%
Sales Q2Q%6.94%
Revenue Next Year3.25%
Revenue Next 2Y3.51%
Revenue Next 3Y3.41%
Revenue Next 5Y2.75%
EBIT growth 1Y180.68%
EBIT growth 3Y6.69%
EBIT growth 5Y19.36%
EBIT Next Year43.2%
EBIT Next 3Y17.84%
EBIT Next 5Y13.18%
FCF growth 1Y34.68%
FCF growth 3Y39.26%
FCF growth 5Y32.98%
OCF growth 1Y-18.19%
OCF growth 3Y3.87%
OCF growth 5Y6.11%

UMICORE / NVJP.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of UMICORE (NVJP.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NVJP.DE.


What is the valuation status of UMICORE (NVJP.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to UMICORE (NVJP.DE). This can be considered as Undervalued.


What is the profitability of NVJP stock?

UMICORE (NVJP.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for NVJP stock?

The Price/Earnings (PE) ratio for UMICORE (NVJP.DE) is 14.38 and the Price/Book (PB) ratio is 1.9.


How financially healthy is UMICORE?

The financial health rating of UMICORE (NVJP.DE) is 3 / 10.